Liraglutide for type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

Liraglutide for type 2 diabetes mellitus.

Liraglutide for type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q37874613

about

Liraglutide for type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q37874613

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Liraglutide for type 2 diabetes mellitus.

@en

Liraglutide for type 2 diabetes mellitus.

@nl

type

label

Liraglutide for type 2 diabetes mellitus.

@en

Liraglutide for type 2 diabetes mellitus.

@nl

prefLabel

Liraglutide for type 2 diabetes mellitus.

@en

Liraglutide for type 2 diabetes mellitus.

@nl

P1433

Q37874613-929E2F11-A57A-41E7-8F7B-3E018DBA9852

P1476

Q37874613-A28E24EE-5427-48AD-B9C7-3288D2A9BA36

P2093

Q37874613-0A474945-D60C-4A63-8372-C0AA4EF44B9B

P2860

Q37874613-05AA7128-CACB-4ADC-9470-860C3EE94989

Q37874613-06DCAA94-7BCD-40D6-B29D-8E345138F330

Q37874613-0CDE66E9-52E0-400A-A0FB-F78D5B78D2B0

Q37874613-1110EE33-324B-4C9E-BB39-F6558A65BBE8

Q37874613-1A99FE1B-C657-4464-B32C-714201CD4147

Q37874613-30632064-414B-403B-AE6A-07758F2783D8

Q37874613-32A5293E-21FE-42C8-A7FF-AE4F866245A0

Q37874613-34A854CD-F372-48A4-BD32-099B9E63321B

Q37874613-3565CB71-312D-4FE5-A63C-C8762417A00E

Q37874613-399F9E88-A06F-4DA3-B592-BDAE1CE713EB

P304

Q37874613-147BC907-BC0F-4728-998D-1BD2DEB8663F

P31

Q37874613-BAD14861-FCE2-4A3D-93A6-892B81C75A3B

P356

Q37874613-3AE29583-FF62-4908-9137-36827D7AA666

P407

Q37874613-7F13640D-9429-452A-9266-C7BFF2711307

P433

Q37874613-25F75C72-E1D8-4E92-8A93-45F7084A028A

P478

Q37874613-60829864-3398-4347-A797-6338CB7C0181

P50

Q37874613-19900640-7A5C-40A8-80F9-74C2A6267652

Q37874613-AF8AEA8C-60F9-4B65-BC5B-C4488C82E255

P577

Q37874613-C402ABBE-F0E8-4E54-9ED8-8E97B2E705B4

P698

Q37874613-CC04A850-5A8B-4704-9112-EC8B175FA969

P921

Q37874613-197DF2C5-B453-4C6B-9EE9-E97DE8487E0E

P356

14712598.2011.583641

P1433

Expert Opinion on Biological Therapy

P1476

Liraglutide for type 2 diabetes mellitus.

@en

P2093

Ram Kela

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

P304

951-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2011.583641

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Melanie J Davies

P577

2011-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21563859

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes